E Maruya

Summary

Affiliation: Kyoto City Hospital
Country: Japan

Publications

  1. ncbi request reprint Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia
    N Ochiai
    Second Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Bone Marrow Transplant 30:793-6. 2002
  2. ncbi request reprint Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants
    E Maruya
    Department of Research, Kyoto Red Cross Blood Center, Kyoto, Japan the Department of Internal Medicine, Saku Central Hospital, Nagano, The Department of Transfusion Medicine, Yamaguchi University Hospital, Japan
    Blood 92:2169-76. 1998
  3. doi request reprint Modified ELISPOT assay may predict T-cell hyporesponsiveness to non-inherited maternal antigens
    K Taniguchi
    Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Int J Lab Hematol 32:e163-8. 2010
  4. ncbi request reprint PCR-LIS-SSCP (Low ionic strength single-stranded conformation polymorphism)--a simple method for high-resolution allele typing of HLA-DRB1, -DQB1, and -DPB1
    E Maruya
    Kyoto Red Cross Blood Center, Japan
    Genome Res 6:51-7. 1996
  5. ncbi request reprint Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome
    S Kumagai
    Kobe University Medical School, Japan
    Arthritis Rheum 40:1685-92. 1997
  6. ncbi request reprint Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling
    K Ikegame
    Department of Molecular Medicine, Osaka University Graduate School of Medicine, Japan
    Bone Marrow Transplant 31:507-10. 2003
  7. ncbi request reprint Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism
    Y Tsutsumi
    Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan
    Bone Marrow Transplant 34:267-9. 2004
  8. ncbi request reprint Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies
    T Yoshihara
    Bone Marrow Transplant 34:373-5. 2004
  9. ncbi request reprint Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchim
    S Fuchida
    Bone Marrow Transplant 35:1031-2. 2005

Collaborators

  • T Inaba
  • Yutaka Tsutsumi
  • Hideki Ishida
  • Junji Tanaka
  • Masahito Yamada
  • H Saji
  • C Shimazaki
  • N Ochiai
  • S Fuchida
  • K Taniguchi
  • E Ashihara
  • T Yoshihara
  • A Okano
  • K Ikegame
  • T Maekawa
  • Y Akatsuka
  • M Taniwaki
  • S Nakano
  • R Uchida
  • M Okamoto
  • N Yamada
  • H Kuroda
  • S Imashuku
  • S Kumagai
  • T Inukai
  • S Nakazawa
  • T Imamura
  • A Morimoto
  • K Goi
  • S Todo
  • K Sugita
  • M Kawakami
  • Y Tanji
  • H Sugiyama
  • H Ogawa
  • H Tamaki
  • N Kitai
  • T Fujioka
  • Y Oka
  • T Sumikuma
  • M Nakagawa
  • N Fujita
  • M Takada
  • S Kanagawa
  • A Morinobu
  • K Nakamura
  • S Sugai

Detail Information

Publications9

  1. ncbi request reprint Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia
    N Ochiai
    Second Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Bone Marrow Transplant 30:793-6. 2002
    ..Bone marrow aspiration on day 120 showed complete remission. Non-TCD HLA haplo-identical HSCT based on feto-maternal microchimerism might be feasible and has important implications in the selection of alternative family donors in HSCT...
  2. ncbi request reprint Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants
    E Maruya
    Department of Research, Kyoto Red Cross Blood Center, Kyoto, Japan the Department of Internal Medicine, Saku Central Hospital, Nagano, The Department of Transfusion Medicine, Yamaguchi University Hospital, Japan
    Blood 92:2169-76. 1998
    ..03) and CD62L + CD49b (P = . 004, Pcorrected = .078) was associated with acute GVHD. Therefore, CD31, CD49b, and CD62L might be candidates for immunodominant mHa...
  3. doi request reprint Modified ELISPOT assay may predict T-cell hyporesponsiveness to non-inherited maternal antigens
    K Taniguchi
    Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Int J Lab Hematol 32:e163-8. 2010
    ..These observations suggest that our IFN-gamma ELISPOT assay-based method may predict the presence of immunological tolerance to NIMA...
  4. ncbi request reprint PCR-LIS-SSCP (Low ionic strength single-stranded conformation polymorphism)--a simple method for high-resolution allele typing of HLA-DRB1, -DQB1, and -DPB1
    E Maruya
    Kyoto Red Cross Blood Center, Japan
    Genome Res 6:51-7. 1996
    ..It is simple, rapid, and cost effective, requiring neither radioisotopes nor enzymes to confirm the typing results of other methods...
  5. ncbi request reprint Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome
    S Kumagai
    Kobe University Medical School, Japan
    Arthritis Rheum 40:1685-92. 1997
    ....
  6. ncbi request reprint Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling
    K Ikegame
    Department of Molecular Medicine, Osaka University Graduate School of Medicine, Japan
    Bone Marrow Transplant 31:507-10. 2003
    ..The patient is still in complete remission past day +400. We suggest that unmanipulated HLA-mismatched transplantation with intensified GVHD prophylaxis is an alternative option for patients who do not have an HLA-identical donor...
  7. ncbi request reprint Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haploidentical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism
    Y Tsutsumi
    Department of Internal Medicine, Hakodate Municipal Hospital, Hakodate, Japan
    Bone Marrow Transplant 34:267-9. 2004
    ..The result suggests that a long-term fetomaternal microchimerism-positive sibling can be a second-line donor if an alternative HLA-identical donor is not available...
  8. ncbi request reprint Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies
    T Yoshihara
    Bone Marrow Transplant 34:373-5. 2004
  9. ncbi request reprint Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchim
    S Fuchida
    Bone Marrow Transplant 35:1031-2. 2005